|
CDCA8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.069400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.525800E-01 |
| Normal-vs-Stage2 |
7.875700E-02 |
| Normal-vs-Stage3 |
6.265000E-01 |
| Normal-vs-Stage4 |
9.087800E-01 |
| Stage1-vs-Stage2 |
6.991000E-04 |
| Stage1-vs-Stage3 |
8.278200E-01 |
| Stage1-vs-Stage4 |
3.805800E-01 |
| Stage2-vs-Stage3 |
4.145000E-03 |
| Stage2-vs-Stage4 |
3.263800E-03 |
| Stage3-vs-Stage4 |
5.315200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.848000E-01 |
| Normal-vs-AfricanAmerican |
3.595600E-01 |
| Normal-vs-Asian |
4.839600E-01 |
| Caucasian-vs-AfricanAmerican |
3.688000E-01 |
| Caucasian-vs-Asian |
4.450000E-01 |
| AfricanAmerican-vs-Asian |
6.220400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.539600E-01 |
| Normal-vs-Female |
4.966600E-01 |
| Male-vs-Female |
8.401400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.314400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.799600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.277200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.357800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.343100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.249800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.913600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.898200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.994300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.756000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.269600E-01 |
| Classical-VS-Follicular |
2.382800E-04 |
| Classical-VS-Other |
3.504400E-02 |
| Classical-VS-Normal |
7.627600E-01 |
| Tall-VS-Follicular |
2.148300E-02 |
| Tall-VS-Other |
6.001500E-02 |
| Tall-VS-Normal |
8.870200E-01 |
| Follicular-VS-Other |
9.492600E-01 |
| Follicular-VS-Normal |
8.916300E-02 |
| Other-VS-Normal |
1.134440E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.233000E-01 |
| Normal-vs-N1 |
2.624800E-01 |
| N0-vs-N1 |
4.009400E-01 |
|
|
